About: Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 September 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2018 (uk) article scientifique publié en 2018 (fr) artículu científicu espublizáu en setiembre de 2018 (ast) scientific article published on 11 September 2018 (en) 2018 թվականի սեպտեմբերի 11-ին հրատարակված գիտական հոդված (hy)
publication date	wds:Q91370927-BA8AFF1B-32EB-41DD-8BB6-151FE0DDF847
publication date	2018-09-11 00:00:00Z (xsd:dateTime)
cites work	wds:Q91370927-340DDC9F-A733-4227-BF15-907CB42DD6FA wds:Q91370927-426BDC67-C7E8-4F0F-A623-DD06DF14FE26 wds:Q91370927-5E1743DE-C109-408A-AC81-EE2FB26649D0 wds:Q91370927-677D9C94-0C48-4EC8-A9F7-F0DB220BEE33 wds:Q91370927-8F45E54C-7D76-4F1B-9909-DC09E23F022B wds:Q91370927-8F66FF35-26AA-4950-A005-C38FA85623BA wds:Q91370927-9D1D80CE-77C4-4027-8824-05022C239C3A wds:Q91370927-9DA4035D-0091-43C8-AD62-DD59EA6FDAAC wds:Q91370927-B05A6639-4CA8-4519-8E5B-DDF628853BC1 wds:Q91370927-C7037ACF-007A-4251-8697-E0888B157C97 wds:Q91370927-DAEDBE05-517E-40F6-B2C7-A6414D58FB15
cites work	Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial Pembrolizumab versus Ipilimumab in Advanced Melanoma Incidence of noncutaneous melanomas in the U.S. Primary mucosal melanoma The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma Outcomes in patients with mucosal melanomas Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041) Whole-genome landscapes of major melanoma subtypes. Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis Efficacy of immunotherapy for metastatic mucosal melanoma.
author name string	wds:Q91370927-3DC86123-D4F5-4173-BF9F-261FC7346B1A wds:Q91370927-44CF835E-02D1-4078-8797-0C1AF5A516A4 wds:Q91370927-548F329D-B672-45EF-BBB3-35AF914DCE81 wds:Q91370927-56C32AC0-058B-44DD-B04B-D11AED8790AC wds:Q91370927-A27862BE-D303-4A49-8DE2-7430BD5544DF wds:Q91370927-BB6A8F68-14E8-4613-BE8B-0F8BD3C33DA4 wds:Q91370927-C0502EBE-5F83-499E-89A7-352F139C30E3 wds:Q91370927-C34A7C60-6967-45CF-997B-439470EB35F3 wds:Q91370927-C65EC74D-250B-4B9C-8FCE-7CEBA96886BE wds:Q91370927-E885361E-05C1-43FA-83A7-427964F911B6
author name string	Omid Hamid Caroline Robert Christoph Hoeller Scot Ebbinghaus Nageatte Ibrahim Adil Daud Jianmin Long Ewan Brown Marcus Butler Ana S Arance
rdfs:label	Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 (en) Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 (nl)
skos:prefLabel	Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 (en) Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 (nl)
name	Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 (en) Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 (nl)
author	wds:Q91370927-722BCD77-510D-4E11-AE4B-39E6042DB51E wds:Q91370927-76517303-E9FE-47AB-84FD-B5A550AE5E4A wds:Q91370927-8A3F0004-64A1-46CE-9F1C-63A9A04847A1 wds:Q91370927-BFB0291F-95BF-4F11-B33A-B7475FED2494 wds:Q91370927-E30BF330-FE18-49F5-A4B3-E90F0A0C3397
author	Antoni Ribas F Stephen Hodi Laurent Mortier Jacob Schachter Euan Walpole
title	wds:Q91370927-C1B21740-395E-4119-AB53-0C9A5C6DDF74
title	Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 (en)
page(s)	wds:Q91370927-96F8FA0E-EE6A-4EDF-94EB-D7F57952DDA8
page(s)	670-674
instance of	wds:Q91370927-27825653-FBA6-40D6-818B-85417738DB8B
instance of	scholarly article
main subject	wds:Q91370927-4E583243-2E15-4B2D-8A1F-DA6980336437 wds:Q91370927-D2AF9E8D-EC9B-4F3F-ACF6-354EC41D52B6
main subject	pembrolizumab mucosal melanoma
PubMed ID	wds:Q91370927-7001C177-19D9-4237-857C-70EBD607EDF9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30202085
PubMed ID	30202085
published in	wds:Q91370927-930B1C20-5B21-45AE-9783-9538D8B01DAC
published in	British Journal of Cancer
issue	wds:Q91370927-C69BCFC2-C9EA-4FC9-9528-37B839624F7B
volume	wds:Q91370927-512225C9-2D52-43EF-B3B2-938E93A18E0E
issue	6
volume	119
DOI	wds:Q91370927-6850E982-B187-4DDF-BA43-5E3A53DF7EE6
DOI	http://dx.doi.org/10.1038/S41416-018-0207-6
DOI	10.1038/S41416-018-0207-6
copyright license	wds:Q91370927-442db023-1ef7-4b31-a98f-f4995fc16a36
copyright status	wds:Q91370927-e5cf2b39-f783-4b72-b582-95660cc9180c
copyright license	Creative Commons Attribution 4.0 International
copyright status	copyrighted
PMCID	wds:Q91370927-F99B4884-DD77-4C0A-ABAD-843C138FB9FD
PMCID	6173747
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91370927
is cites work of	Metabolic syndrome is a risk factor for cancer mortality in the general Japanese population: the Jichi Medical School Cohort Study A Rare Case of Primary Anorectal Melanoma and a Review of the Current Landscape of Therapy Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in wild-type advanced non-small cell lung cancer [What's new in oncodermatology?]

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software